Skip to main content
Caplight Logo









ANEUVO

ANEUVO

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://aneuvo.com/

Last Round

Series C

Mar 5, 2026

Total Funding Raised

$30.37M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ANEUVO is a medical technology company that develops bioelectronic medicine and non-invasive neuromodulation devices to treat disabling injuries and conditions such as spinal cord injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuromodulationspinal cord injurymedical deviceelectrical stimulationrehabilitation technologyneurotechmotor function recoverytranscutaneous stimulationFDA-cleared deviceclinical rehabilitationbioelectronic medicineneural pathwaysassistive technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ANEUVO Comparables

Compare ANEUVO with similar companies based on industry and business-model similarity.

ANEUVO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ONWARD Medical N.V.
87%
SpineX Inc.
84%
Soterix Medical
72%

ANEUVO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 5, 2026
GrantOct 28, 2021
GrantSep 7, 2021
Series AOct 23, 2018
GrantDec 1, 2016

Key People

Founding team and executive leadership

Yi-Kai Lo

Chief Executive Officer

Executive Team

ANEUVO Investors

Notable investors and investment history

ANEUVO investors
InvestorRounds
UCLA Innovation FundGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 33, 2.4x the trailing average.

  • Jul 25, 2026

    Monthly visitors increased 51% MoM.

Recent news

Latest coverage and updates

  • is_developingAug 19, 2026

    ANEUVO International is developing revolutionary bioelectronic medicine.

ANEUVO Filings

Explore SEC and related filing metadata, where available.

ANEUVO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ANEUVO's valuation, stock price, and market status.

Is ANEUVO a public or private company?

ANEUVO is a private company.

What is the current stock price of ANEUVO?

ANEUVO is a private company with no public stock price. No recent secondary market data is available.

How much is ANEUVO worth (valuation)?

Valuation information for ANEUVO is not publicly available.

Can I buy ANEUVO stock?

ANEUVO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ANEUVO's last funding round?

ANEUVO's most recent funding round was Series C on March 5, 2026.

Who are the main investors in ANEUVO?

Key investors in ANEUVO include UCLA Innovation Fund, National Science Foundation.

Will ANEUVO IPO soon?

No public IPO plans have been announced for ANEUVO.

How can I track ANEUVO secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ANEUVO's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range26
Year Founded2016
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?